A novel strategy for predicting critical illness in hospital-acquired COVID-19
-
Woo Hyun Cho1,2
- Received April 16, 2024; Accepted April 19, 2024;
Coronavirus disease 2019 (COVID-19) had a marked effect on healthcare systems and daily practice of care in hospitals [1,2]. Many people died from COVID-19 during the pandemic [3]. Mortality due to COVID-19 was associated with demographic factors, comorbidities, and the initial laboratory findings [4]. Social distancing and meticulous precautions were the only preventive methods in the early part of the pandemic. However, nosocomial spread occurred from healthcare providers to patients, as well as from patient to patient [5]. Given the high prevalence of comorbidities in hospitalized patients, nosocomial transmission could be a secondary factor leading to overwhelming outbreaks in hospitals. Critically ill COVID-19 patients require enormous healthcare resources, including manpower, isolation facilities, and critical care equipment, such as monitoring facilities, oxygen suppl y devices, and mechanical ventilators. The locoregional spread of the outbreak led to severe congestion in critical care systems and was ultimately associated with high mortality [6–8].
A recent study on the risk factors for progression to critical illness in hospital-acquired COVID-19 shed light on a crucial aspect of patient management during the pandemic. The findings underscore the importance of early identification and intervention in patients at the highest risk of severe outcomes, offering a stark reminder of the vulnerabilities within healthcare systems. In that study, 18.1% of hospital-acquired COVID-19 cases progressed to a critically ill condition, defined as acute respiratory distress syndrome, septic shock, or the need for life-sustaining therapy. Given that 5–10% of community-acquired COVID-19 cases progress to critical illness [9,10], those with hospital-acquired COVID-19 comprise a highly vulnerable cohort with respect to progression to critical illness. Moreover, 54.1% of the study cohort that progressed to a critically ill condition died in hospital. Once progression to a critical illness occurs, the likelihood of a hospital stay increases by two-fold, ultimately placing a significant burden on the healthcare system due to the requirement for life-sustaining therapies.
Lee et al. [11] presented background data and perspectives on risk stratification for hospital-acquired COVID-19 cases that will likely progress to a critical condition. They also discussed the management of nosocomial COVID-19 transmission. Baseline organ function, pre-existing frailty, and specific comorbidities including an immunocompromised state and cardiovascular disease were found to be risk factors for critical illness in nosocomial transmission. Based on these findings, preemptive treatment, surveillance, and quarantine could alleviate the strain on hospital resources by potentially reducing the number of patients who require critical care.
Throughout the pandemic, many healthcare workers developed psychological burnout and fear of infection, and suffered from the physical burden imposed by caring for critically ill COVID-19 patients. This study reminds us that our healthcare systems must be dynamic, responsive, and ever-vigilant. As we continue to navigate the challenges posed by COVID-19, we should use the insights from such research to refine our approaches, protect our most vulnerable populations, and strive for better outcomes for all patients.
- Conflicts of Interest
- Conflicts of Interest
-
Conflicts of interest The author discloses no conflicts.
- Notes
- Notes
-
Funding This study was supported by a 2023 research grant from Pusan National University Yangsan Hospital.
- References
- References
REFERENCES
1. Ahmad FB, Cisewski JA, Xu J, Anderson RN. COVID-19 mortality update - United States, 2022. MMWR Morb Mortal Wkly Rep 2023;72:493–496.
[Article] [PubMed] [PMC]2. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020;323:2052–2059.
[Article] [PubMed] [PMC]3. Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus disease 2019 case surveillance - United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:759–765.
[Article] [PubMed] [PMC]4. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020;369:m1966.
[Article] [PubMed] [PMC]5. Wu S, Wang Y, Jin X, Tian J, Liu J, Mao Y. Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019. Am J Infect Control 2020;48:910–914.
[Article] [PubMed] [PMC]6. Emanuel EJ, Persad G, Upshur R, et al. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med 2020;382:2049–2055.
[Article] [PubMed]7. Brown MJ, Goodwin J. Allocating medical resources in the time of Covid-19. N Engl J Med 2020;382:e79.
[Article] [PubMed] [PMC]8. Truog RD, Mitchell C, Daley GQ. The toughest triage - allocating ventilators in a pandemic. N Engl J Med 2020;382:1973–1975.
[Article] [PubMed]9. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–1242.
[Article] [PubMed]